Supernus Pharmaceuticals, Inc. (SUPN)
51.11
-0.06
(-0.12%)
USD |
NASDAQ |
Jan 09, 16:00
51.14
+0.03
(+0.06%)
After-Hours: 20:00
Supernus Pharmaceuticals Research and Development Expense (Annual): 106.36M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amphastar Pharmaceuticals, Inc. | 61.43M |
| BridgeBio Pharma, Inc. | 506.46M |
| Catalyst Pharmaceuticals, Inc. | 12.65M |
| Assembly Biosciences, Inc. | 55.80M |
| Viking Therapeutics, Inc. | 101.64M |